Clinical Trials Browser

Phase 2 × Suspended × spartalizumab × Clear all

NCT06728657 2025-06-18

TORCH-G

Phase 2 Suspended

Gastrointestinal

Stomach Adenocarcinoma

NCT03779100 2019-01-28

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Phase 2 Suspended

Gastrointestinal

Cholangiocarcinoma